A laser treatment developed by Associate Professor Paul Chew from NUS Medicine’s Department of Ophthalmology for glaucoma patients has proven more effective while causing less pain and side effects, according to data from National University Hospital (NUH). The treatment – micropulse transscleral cyclophototherapy (MPTCP) – involves shooting small lasers into the patient's eyes, as opposed to the conventional treatment of transscleral cyclophotoco-agulation (TCP), which uses a high-intensity laser.
Since last year, 300 patients have successfully undergone the treatment at NUH Eye Surgery Centre. The treatment has also been used on 45,000 patients in other countries, such as the United States and the Philippines, over the past two years.
Assoc Prof Chew is also a senior consultant at NUH’s ophthalmology department.